Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Croatia France Germany Greece Ireland +6
  • Study of Vedolizumab for Children with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Denmark Ireland Italy The Netherlands +4
  • Safety and efficacy of stopping versus maintenance dose of filgotinib, tofacitinib and upadacitinib in adult ulcerative colitis patients in deep remission

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

    Not yet recruiting

    2 1
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia France +9
  • Study of ly4395089 and mirikizumab in adults with moderately to severely active Crohn’s disease

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    Belgium Germany Hungary Italy Poland
  • A study comparing vedolizumab, filgotinib, ustekinumab, and infliximab to maintain remission in patients with ulcerative colitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Study on the use of oral vancomycin for children with ulcerative colitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland
  • Using 68Ga-FAPI-46 imaging to detect fibrosis in patients with inflammatory diseases such as Crohn’s disease, ulcerative colitis, systemic sclerosis, and lung fibrosis.

    Not yet recruiting

    2 1 1
    The Netherlands
  • Evaluating Treatment with Autologous Regulatory T-cells Given by Infusion in Adults with Ulcerative Colitis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Germany
  • Study on the Safety and Effectiveness of OD-07656 and Vedolizumab for Patients with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Croatia Czechia Hungary Lithuania +1